US Broker Ratings

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 114% Potential Upside in the CAR-T Space

Legend Biotech Corporation (NASDAQ: LEGN) is positioned at the forefront of the biotechnology sector with its innovative focus on cell therapies for oncology. With a market capitalization of $6.56 billion,..

Gilead Sciences, Inc. (GILD)

⚠️ No article content returned.

..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking the 21.93% Potential Upside

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.46 billion, Avantor specializes in providing..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 8.15% Upside in the Genomics Powerhouse

Illumina, Inc. (ILMN) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.96 billion, Illumina is a trailblazer..

Bio-Techne Corp (TECH) Stock Analysis: Analyst Ratings Highlight 26.61% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor attention with its robust market presence and promising growth potential. With a market capitalization of $8.33..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 92.52% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector should take a closer look at Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage precision oncology company that is drawing significant attention in..

ResMed Inc. (RMD) Stock Analysis: Navigating a 2.93% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector, is capturing the attention of investors with a market cap of $37.68 billion and a robust portfolio of medical..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 41% Potential Upside

Telix Pharmaceuticals Limited (TLX) is emerging as a compelling player in the biotechnology sector, with its promising portfolio of radiopharmaceutical products and impressive market performance. Based in North Melbourne, Australia,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A 25% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors with a potential upside of 25.35% according to analysts’..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 3.85% Potential Upside in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is making waves with its strategic focus on women’s health and its diversified portfolio of diagnostics, medical imaging, and..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 66% Upside Potential Amid Strong Analyst Ratings

For investors with an eye on the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) offers a compelling opportunity. With a market capitalization of $11.03 billion, BioMarin stands as a significant..

Qiagen N.V. (QGEN) Stock Analysis: A Promising 3.71% Upside Potential for Investors

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers an intriguing proposition for investors eyeing steady growth and innovative healthcare solutions...

Haleon plc (HLN) Stock Analysis: Exploring a 12.76% Potential Upside and Robust Market Cap

Haleon plc (HLN), a stalwart in the healthcare sector, commands significant attention from investors with its market cap standing robustly at $46.04 billion. As a prominent player in the Drug..

Encompass Health Corporation (EHC) Stock Analysis: A 10.54% Upside Awaits Investors in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC), a leading provider of post-acute healthcare services, has captured investor attention with an enticing potential upside of 10.54%. With its market capitalization standing at a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 52.41% Potential Upside in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV) is intriguing investors with its promising potential upside of 52.41%, according to the latest analyst ratings. As a clinical-stage biopharmaceutical company, Roivant is at the..

Summit Therapeutics Inc. (SMMT): Investor Outlook on a Biotech with a 42.54% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) presents an intriguing proposition for investors seeking to capitalize on the biotechnology sector’s growth potential. This Miami-based biopharmaceutical company, with a current market cap of..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 43.94% Upside in the Healthcare Sector

In the ever-evolving realm of healthcare, Globus Medical, Inc. (NYSE: GMED) stands out as a key player within the medical devices industry. With its innovative solutions for musculoskeletal disorders, Globus..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: A Biotech Stock with a 41.58% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotech sector with a compelling narrative for investors, driven by its focus on innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH). With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating Growth Potential with an 8.76% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable entity in the biotechnology sector, with a specific focus on groundbreaking therapies for cystic fibrosis (CF). Headquartered in Boston, Massachusetts, this..

Axsome Therapeutics, Inc. (AXSM): Growth Potential with a 67.92% Upside and Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent biopharmaceutical company that has carved a niche in the healthcare sector by focusing on developing innovative treatments for central nervous system (CNS)..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds